Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
A novel non-invasive method for using carbon-13 magnetization transfer effects to determine and evaluate in vivo aspartate transaminase (AST) activity and levels in an organ, as a biomarker of disease and certain neurological disorders. More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Related Reports
Market Research Reports provided by reports.innovaro.com
Jul 2011 - 200 pages - $500
Jul 2011 - 143 pages - $500
Nov 2010 - 500 pages - $1,495
Dec 2010 - 49 pages - $2,000
Jan 2011 - 54 pages - $500
Jul 2011 - 28 pages - $2,000
Jul 2011 - 28 pages - $2,000
Jul 2011 - 27 pages - $2,000
Jul 2011 - 28 pages - $2,000
Jul 2011 - 27 pages - $2,000
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us